🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A large proportion of patients with ABI have cognitive deficits that affect...
Status
Completed
Location
Sunnaas rehabilitation hospital
Start Date
2018-09-01
Trial ID
NCT03636399
Treatments Being Tested
To assess anti-tumor activity of avelumab in combination with axitinib in p...
Status
Completed
Location
Maria Sklodowska-Curie National Research Institue of Oncology
Start Date
2019-04-30
Trial ID
NCT04258956
Treatments Being Tested
This study is a multicenter, prospective, randomized controlled Phase II cl...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital, 52 Fucheng Road
Start Date
2025-07-30
Trial ID
NCT06772233
Treatments Being Tested
Following the ACOSOG Z9001trial, imatinib received market authorization in ...
Status
Unknown
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02576080
Treatments Being Tested
Activating mutations of the kinases CKIT or PDGFRA can be detected in 90% o...
Status
Completed
Location
Klinikum rechts der Isar - III. Medizinische Klinik und Poliklinik
Start Date
2011-11
Trial ID
NCT01462994
The purpose of this Managed Access Program is to provide regorafenib to pat...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01689376
Treatments Being Tested
Imatinib remains suboptimal for recurrence/metastasis and unresectable GIST...
Status
Unknown
Location
Xijing Hospital of Air Force Military Medical University
Start Date
2021-09-10
Trial ID
NCT05895942
Treatments Being Tested
Assuming that PDR001, an anti-PD-1 antibody, with imatinib might be effecti...
Status
Completed
Location
Asan Medical Center
Start Date
2019-02-14
Trial ID
NCT03609424
Treatments Being Tested
Evaluate the reliability of morphology standards for GIST pathologic type, ...
Status
Unknown
Location
180 Fenglin Road
Start Date
2013-07
Trial ID
NCT02353052
Treatments Being Tested
The objective of the trial is to provide regorafenib to subjects diagnosed ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01646593
Treatments Being Tested